Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mattia Giovannini
Omalizumab and Mepolizumab in the Landscape of Biological Therapy for Severe Asthma in Children: How to Choose?
Italian Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Related publications
Therapeutic Switch From Omalizumab to Mepolizumab in Patients With Uncontrolled Severe Eosinophilic Asthma: Treatment Effect by Prior Omalizumab Treatment Duration
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Efficacy and Safety of Treatment With Biologicals (Benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma
Allergy: European Journal of Allergy and Clinical Immunology
Allergy
Immunology
PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in Thailand
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Omalizumab as Add‐on Therapy in a Patient With Severe Asthma and OSA
Respirology Case Reports
Pulmonary
Respiratory Medicine
Mepolizumab for Severe Refractory Eosinophilic Asthma: Evidence to Date and Clinical Potential
Therapeutic Advances in Chronic Disease
Medicine
Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?
European Clinical Respiratory Journal
A Review of Omalizumab for the Management of Severe Asthma
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia
Journal of Allergy and Clinical Immunology
Allergy
Immunology
The Long-Term Omalizumab Therapy in Children With Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry
Pediatric pharmacology
